Related references
Note: Only part of the references are listed.Long-Term Safety and Efficacy of Subcutaneous Tanezumab Versus Nonsteroidal Antiinflammatory Drugs for Hip or Knee Osteoarthritis: A Randomized Trial
Marc C. Hochberg et al.
ARTHRITIS & RHEUMATOLOGY (2021)
Subcutaneous tanezumab for osteoarthritis of the hip or knee: efficacy and safety results from a 24-week randomised phase III study with a 24-week follow-up period
Francis Berenbaum et al.
ANNALS OF THE RHEUMATIC DISEASES (2020)
Pooled analysis of tanezumab efficacy and safety with subgroup analyses of phase III clinical trials in patients with osteoarthritis pain of the knee or hip
Leslie Tive et al.
JOURNAL OF PAIN RESEARCH (2019)
Nerve growth factor antibody for the treatment of osteoarthritis pain and chronic low-back pain: mechanism of action in the context of efficacy and safety
Martin Schmelz et al.
PAIN (2019)
Effect of Tanezumab on Joint Pain, Physical Function, and Patient Global Assessment of Osteoarthritis Among Patients With Osteoarthritis of the Hip or Knee A Randomized Clinical Trial
Thomas J. Schnitzer et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2019)
The Efficacy, Tolerability, and Joint Safety of Fasinumab in Osteoarthritis Pain: A Phase IIb/III Double-Blind, Placebo-Controlled, Randomized Clinical Trial
Paula Dakin et al.
ARTHRITIS & RHEUMATOLOGY (2019)
Tanezumab: Therapy targeting nerve growth factor in pain pathogenesis
Mona K. Patel et al.
JOURNAL OF ANAESTHESIOLOGY CLINICAL PHARMACOLOGY (2018)
Exploring the Role of Tanezumab as a Novel Treatment for the Relief of Neuropathic Pain
Candace Bramson et al.
PAIN MEDICINE (2015)
Efficacy and Safety of Intravenous Tanezumab for the Symptomatic Treatment of Osteoarthritis: 2 Randomized Controlled Trials versus Naproxen
Evan F. Ekman et al.
JOURNAL OF RHEUMATOLOGY (2014)
Nerve safety of tanezumab, a nerve growth factor inhibitor for pain treatment
Mark T. Brown et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2014)
A phase III placebo- and oxycodone-controlled study of tanezumab in adults with osteoarthritis pain of the hip or knee
Egilius L. H. Spierings et al.
PAIN (2013)
Antagonism of Nerve Growth Factor-TrkA Signaling and the Relief of Pain
Patrick W. Mantyh et al.
ANESTHESIOLOGY (2011)
Tanezumab for the Treatment of Pain from Osteoarthritis of the Knee
Nancy E. Lane et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Nerve growth factor and expression of its receptors in patients with diabetic neuropathy
H. C. Kim et al.
DIABETIC MEDICINE (2009)
Nerve growth factor expression and innervation of the painful intervertebral disc
AJ Freemont et al.
JOURNAL OF PATHOLOGY (2002)
Share Paper
